#ArQule Inc (ARQL)

GATTEX FOR SHORT BOWEL SYNDROME RECOMMENDED FOR APPROVAL NPS PHARMACEUTICALS (NPSP) The advisory panel recommended approval of  NPS Pharmaceuticals’  experimental bowel drug  Gattex  for short bowel s...

This week’s bearish and bullish analysts will focus on  ASCO . The difference, though, is that positive analysts will highlight firms that have promising products, while most negative analysts will de...

The market opened down today. Our cancer stocks, IMGN, SGEN are up, while INCY, and ARIA, seem to be losing a little to profit-takings. ONXX and PCYC are rallying. DNDN is the largest loser. We will t...